Research Article
A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway
Figure 15
Probable molecular mechanistic pathway of the ruthenium-fluvastatin complex in the induction of apoptosis in breast cancer.